Results
74,735 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 23 | Higgins John GerardChief, Client &Partner Success |  PEGAPEGASYSTEMS INCOption exercise | M | — 2,202 sh | Sep 9, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 23 | Higgins John GerardChief, Client &Partner Success | PEGAPEGASYSTEMS INC Option exercise | M | — 2,202 sh | Sep 9, 2026 |
| 23 | Candelino RobertoDirector |  SMGSCOTTS MIRACLE-GRO COGrant or award | A | — 77 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 23 |  April McClain DelaneyDDependent child |  SCISERVICE CORP INTERNATIONALSale | SELL | $50K – $100K | Sep 9, 2026 traded Aug 25, 2026 |
| 23 | Engelhardt Eva AnetteEVP, President, CDG |  BIOBIO.BBIO-RAD LABORATORIES, INC.Option exercise | M | — 1,152 sh | Sep 9, 2026 traded Sep 6, 2026 |
| 23 | Mehta RajatEVP, GBL Commercial Operations | BIOBIO.BBIO-RAD LABORATORIES, INC. Option exercise | M | — 456 sh | Sep 9, 2026 traded Sep 5, 2026 |
| 23 | April McClain DelaneyDDependent child |  STESTERIS plcSale | SELL | $100K – $250K | Sep 9, 2026 traded Aug 25, 2026 |
| 23 | Barry JamesEVP, President, LSG | BIOBIO.BBIO-RAD LABORATORIES, INC. Option exercise | M | — 1,056 sh | Sep 9, 2026 traded Sep 6, 2026 |
| 23 | April McClain DelaneyDDependent child |  EMEEMCOR Group, Inc.Sale | SELL | $100K – $250K | Sep 9, 2026 traded Aug 25, 2026 |
| 23 | Purcell Lynn SebastianDirector, 10% Owner |  CNXUConexeu Sciences Inc.In-the-money exercise | X | $218 217.6K sh | Sep 9, 2026 traded Sep 4, 2026 |
| 23 | April McClain DelaneyDDependent child |  MKLMARKEL GROUP INC.Sale | SELL | $100K – $250K | Sep 9, 2026 traded Aug 25, 2026 |
| 23 | April McClain DelaneyDDependent child |  LYVLive Nation Entertainment, Inc.Sale | SELL | $100K – $250K | Sep 9, 2026 traded Aug 25, 2026 |
| 23 | Allison SchwartzDirector | BIOBIO.BBIO-RAD LABORATORIES, INC. Option exercise | M | — 228 sh | Sep 9, 2026 traded Sep 5, 2026 |
| 23 | Miller Austin ScottDirector | SMGSCOTTS MIRACLE-GRO CO Grant or award | A | — 53 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 23 | April McClain DelaneyDDependent child |  SGISOMNIGROUP INTERNATIONAL INC.Sale | SELL | $100K – $250K | Sep 9, 2026 traded Aug 25, 2026 |
| 23 | Maguire Scott AndrewCOO |  ONONOn Holding AGOption exercise | M | — 3,772 sh | Sep 9, 2026 traded Sep 5, 2026 |
| 23 | Zugelder DanEVP, Chief Revenue Officer |  DTDynatrace, Inc.Option exercise | M | — 6,388 sh | Sep 9, 2026 traded Sep 5, 2026 |
| 22 | Winn Charles Brent Jr.CHIEF FINANCIAL OFFICER |  MDRRMedalist Diversified, Inc.Open-market purchase | BUY | $3,240 270 sh | Sep 9, 2026 traded Sep 8, 2026 |
| 22 | Lee Bryan MChief Financial Officer |  FIVNFive9, Inc.Open-market sale · 10b5-1 plan | SELL | $215K 6,500 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 22 | Russotti GregorySee Remarks |  IPSCCentury Therapeutics, Inc.Open-market sale | SELL | $1,095 534 sh | Sep 9, 2026 traded Sep 8, 2026 |
| 22 | Scheiwer Mark JEVP, CFO & CAO | SMGSCOTTS MIRACLE-GRO CO Other acquisition or disposition | J | $150 3 sh | Sep 9, 2026 traded Aug 31, 2026 |
| 22 | Winn Charles Brent Jr.CHIEF FINANCIAL OFFICER | MDRRMedalist Diversified, Inc. Open-market purchase | BUY | $588 49 sh | Sep 9, 2026 traded Sep 9, 2026 |
| 22 | Dignan AndyPresident | FIVNFive9, Inc. Open-market sale · 10b5-1 plan | SELL | $147K 4,379 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 22 | Landman YoavDirector, CHIEF TECHNOLOGY OFFICER |  FROGJFrog LtdOpen-market sale · 10b5-1 plan | SELL | $239K 2,700 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 22 | Engelhardt Eva AnetteEVP, President, CDG | BIOBIO.BBIO-RAD LABORATORIES, INC. Tax withholding | F | $187K 485 sh | Sep 9, 2026 traded Sep 6, 2026 |
| 22 | Dignan AndyPresident | FIVNFive9, Inc. Open-market sale · 10b5-1 plan | SELL | $96K 2,900 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 22 | Asmerom AmineChief Accounting Officer |  CHYMChime Financial, Inc.Open-market sale · 10b5-1 plan | SELL | $317K 9,505 sh | Sep 9, 2026 traded Sep 8, 2026 |
| 22 | Romanko MichaelSee Remarks |  WOOFPetco Health & Wellness Company, Inc.Tax withholding | F | $227K 90.1K sh | Sep 9, 2026 traded Sep 4, 2026 |
| 22 | Evran SedatEVP, Global Supply Chain | BIOBIO.BBIO-RAD LABORATORIES, INC. Tax withholding | F | $127K 329 sh | Sep 9, 2026 traded Sep 5, 2026 |
| 22 | Dignan AndyPresident | FIVNFive9, Inc. Open-market sale · 10b5-1 plan | SELL | $110K 3,295 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 22 | Engelhardt Eva AnetteEVP, President, CDG | BIOBIO.BBIO-RAD LABORATORIES, INC. Tax withholding | F | $142K 369 sh | Sep 9, 2026 traded Sep 5, 2026 |
| 22 | Barry JamesEVP, President, LSG | BIOBIO.BBIO-RAD LABORATORIES, INC. Tax withholding | F | $181K 470 sh | Sep 9, 2026 traded Sep 6, 2026 |
| 22 | Barry JamesEVP, President, LSG | BIOBIO.BBIO-RAD LABORATORIES, INC. Tax withholding | F | $142K 369 sh | Sep 9, 2026 traded Sep 5, 2026 |
| 22 | Evran SedatEVP, Global Supply Chain | BIOBIO.BBIO-RAD LABORATORIES, INC. Tax withholding | F | $107K 277 sh | Sep 9, 2026 traded Sep 6, 2026 |
| 22 | Asmerom AmineChief Accounting Officer | CHYMChime Financial, Inc. Open-market sale · 10b5-1 plan | SELL | $325K 10.0K sh | Sep 9, 2026 traded Sep 8, 2026 |
| 22 | Lee Bryan MChief Financial Officer | FIVNFive9, Inc. Open-market sale · 10b5-1 plan | SELL | $167K 4,995 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 22 | Simmons SabrinaChief Financial Officer | WOOFPetco Health & Wellness Company, Inc. Tax withholding | F | $215K 85.3K sh | Sep 9, 2026 traded Sep 4, 2026 |
| 21 | April McClain DelaneyDDependent child |  CHRWC. H. ROBINSON WORLDWIDE, INC.Purchase | BUY | $1,001 – $15K | Sep 9, 2026 traded Aug 5, 2026 |
| 21 | Budur KumarCHIEF MEDICAL OFFICER |  HRMYHarmony Biosciences Holdings, Inc.Open-market sale | SELL | $43K 1,000 sh | Sep 9, 2026 traded Sep 8, 2026 |
| 21 | April McClain DelaneyDDependent child |  HUBBHUBBELL INCPurchase | BUY | $1,001 – $15K | Sep 9, 2026 traded Aug 3, 2026 |
| 21 | Carter Philip MatthewSVP & Chief Financial Officer |  SWKSSKYWORKS SOLUTIONS, INC.Option exercise | M | — 9,917 sh | Sep 9, 2026 traded Sep 8, 2026 |